Research & Development
12 November 2018 - - US-based biotechnology company Cancer Targeted Technology has filed an Investigational New Drug Application with the FDA to move forward a radiotherapeutic drug, CTT1403, into hum...
9 November 2018 - Xencor Inc (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseas...
8 November 2018 - - US-based Aveo Oncology (NASDAQ: AVEO) has received positive topline results from the primary analysis of the TIVO-3 trial, the company's Phase 3 randomised, controlled, multi-...
7 November 2018 - Axonics Modulation Technologies Inc (NASDAQ: AXNX), developer of the rechargeable Sacral Neuromodulation (r-SNM) system urinary and bowel dysfunction treatment, declared on Wednesday...
7 November 2018 - Sectra (STO: SECT B), an international medical imaging IT and cybersecurity company, declared on Wednesday that it has received an order from US-based Kettering Health Network (KHN) ...
7 November 2018 - - US-based biotechnology company Seattle Genetics, Inc. (NASDAQ: SGEN) has submitted a supplemental Biologics License Application to the US Food and Drug Administration based on...
Related Headlines